Data as of Nov 26
| +0.72 / +0.43%|
C.R. Bard, Inc. designs, manufactures, distributes and sells medical, surgical, diagnostic and patient care devices. The company operates its business through only one segment, manufacturing and selling of medical devices. It sells a broad range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The company's products include Vascular, Urology, Oncology and Surgical Specialties. The Vascular products cover a wide range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. The Urology products include basic drainage products, continence products and urological specialty products. The Oncology products cover a wide range of devices used in the treatment and management of various cancers and other diseases and disorders. The Surgical Specialties products include implanted patches and fixation systems for hernia and other soft tissue repairs, irrigation devices for orthopedic, laparoscopic and gynecological procedures and products for topical hemostasis. C. R. Bard was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.
|Tim M. Ring||Chairman & Chief Executive Officer|
|John H. Weiland||President, Chief Operating Officer & Director|
|Christopher S. Holland||Chief Financial Officer & Senior Vice President|
|John A. DeFord||Senior VP-Science, Technology & Clinical Affairs|
|Patricia G. Christian||VP-Quality, Regulatory & Medical Affairs|